Historic Net Income for Nuvation Bio (NUVB) over the last 5 years, with Jun 2025 value amounting to -$59.0 million.
- Nuvation Bio's Net Income rose 87.24% to -$59.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$202.9 million, marking a year-over-year increase of 60.27%. This contributed to the annual value of -$567.9 million for FY2024, which is 649.24% down from last year.
- Nuvation Bio's Net Income amounted to -$59.0 million in Q2 2025, which was down 10.84% from -$53.2 million recorded in Q1 2025.
- Nuvation Bio's 5-year Net Income high stood at -$13.8 million for Q4 2023, and its period low was -$462.5 million during Q2 2024.
- For the 3-year period, Nuvation Bio's Net Income averaged around -$75.6 million, with its median value being -$31.5 million (2023).
- Its Net Income has fluctuated over the past 5 years, first plummeted by 2,140.76% in 2024, then surged by 87.24% in 2025.
- Nuvation Bio's Net Income (Quarterly) stood at -$25.1 million in 2021, then increased by 17.06% to -$20.8 million in 2022, then surged by 33.86% to -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then surged by 87.24% to -$59.0 million in 2025.
- Its Net Income was -$59.0 million in Q2 2025, compared to -$53.2 million in Q1 2025 and -$49.4 million in Q4 2024.
